Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.

Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors. J Natl Compr Canc Netw. 2019 05 01; 17(5):459-468.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Cancer Survivors
Genetic Variation
Humans
Hypogonadism
Male
Middle Aged
Neoplasm Staging
Odds Ratio
Patient Outcome Assessment
Patient Reported Outcome Measures
Risk Factors
Testicular Neoplasms
Young Adult

authors with profiles

Mary Dolan